CIK 0001818382 · Non-accelerated filer<br>Smaller reporting company
Humacyte, Inc.
Sign in to watch- Ticker
- HUMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851763759
- Phone
- 919-313-9633
- Business address
- 2525 EAST NORTH CAROLINA HIGHWAY 54, DURHAM, NC, 27713
- Former names
- Alpha Healthcare Acquisition Corp.
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market sale Director sold 881,878 shares at an average $6.49 ($5,724,139)
- 4 Open-market sale President, CEO and Director sold 881,878 shares at an average $6.49 ($5,724,139)
- 4 Open-market sale CFO and Chief Corp. Deve. Off. sold 39,389 shares at $6.68 ($263,119)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market buy Director bought 3,100 shares at $6.29 ($19,494)
- 10-Q Report Quarterly Report
- UPLOAD Other SEC-generated Letter
- 8-K Event Results of operations · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- 4 Option exercise Director acquired 39,389 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 9 of 26 · 506 filings